ARCHIVES

Phase II Study of Veliparib Improves PFS by 35 Percent

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

DCT Announces Neutron Therapy RFP Available

January 19, 1979

Review Of NTP Could Lead To Administrative Changes

April 18, 1980

Marker Research Plans Described; NCAB May Consider Asking For Special Study Section For Those Grants

March 11, 1983

SBIR Solicitation Issued

September 13, 1996

Medicare Expands Coverage for Lymphedema Pumps.

May 11, 2001

NCI Budget: About Half Of Increase In President’s Budget Would Fund Grants

February 13, 1998